Global Aneurysm Treatment Market, By Type (Aortic Aneurysm, Cerebral Aneurysm, and Others), Shape (Fusiform Aneurysms Bulge, Saccular Aneurysms Bulge, Others), Treatment Type (Medication, Surgery, and Others), Route of Administration (Oral, Injectable, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), and Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Aneurysm Treatment Market
The aneurysm treatment market is expected to witness market growth at a rate of 8% in the forecast period of 2021 to 2028. Data Bridge Market Research report on the aneurysm treatment market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the population of smokers and consumers of tobacco is escalating the growth of the aneurysm treatment market.
An aneurysm is referred to as a condition that happens when the arterial walls weaken and cause abnormal expansion of arteries. Aneurysms normally happen in the aorta, brain, spleen, and legs.
Major factors that are expected to boost the growth of the aneurysm treatment market in the forecast period are the rise in the prevalence of brain aneurysms. Furthermore, the increase in the incidence of hypertension and brain aneurysms is further anticipated to propel the growth of the aneurysm treatment market. On the other hand, the rise in the management expenses of aneurysmal subarachnoid hemorrhage is further projected to impede the growth of the aneurysm treatment market in the timeline period.
In addition, the rise in the developments in surgical tools and techniques will further provide potential opportunities for the growth of the aneurysm treatment market in the coming years. However, the complications involved in the surgeries in many cases of aneurysms, especially the brain, might further challenge the growth of the aneurysm treatment market in the near future.
The aneurysm treatment market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the aneurysm treatment market scenario, contact Data bridge market research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Aneurysm Treatment Market Scope and Market Size
The aneurysm treatment market is segmented on the basis of type, shape, treatment type, route of administration, end-users, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the aneurysm treatment market is segmented into an aortic aneurysm, cerebral aneurysm, and others.
- On the basis of shape, the aneurysm treatment market is segmented into fusiform aneurysms bulge, saccular aneurysms bulge, and others.
- On the basis of treatment type, the aneurysm treatment market is segmented into medication, surgery, and others.
- On the basis of route of administration, the aneurysm treatment market is segmented into oral, injectable, and others.
- On the basis of end-users, the aneurysm treatment market is segmented into hospitals, home care, specialty clinics, and others.
- On the basis of distribution channels, the aneurysm treatment market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others.
Aneurysm Treatment Market Country Level Analysis
The aneurysm treatment market is analyzed, and market size information is provided by country, type, shape, treatment type, route of administration, end-users, and distribution channel as referenced above.
The countries covered in the aneurysm treatment market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).
North America dominates the aneurysm treatment market due to the rise in the geriatric population. Furthermore, the increase in the prevalence of hypertension and stroke is further anticipated to propel the growth of the aneurysm treatment market in the region during the forecast period. Asia-Pacific is projected to observe a significant amount of growth in the aneurysm treatment market due to the increasing lifestyle stress and the rise in the aging population. Moreover, the rise in the prevalence of hypertension is further anticipated to propel the growth of the aneurysm treatment market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The aneurysm treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyzes of epidemiology to the market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Aneurysm Treatment Market Share Analysis
The aneurysm treatment market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the aneurysm treatment market.
The major players covered in the aneurysm treatment market report are Terumo Medical Corporation, Medtronic, Novartis AG, Abbott, Mylan N.V., InfraScan, Inc., MicroPort Scientific Corporation, Spiegelberg GmbH & Co. KG, WOCKHARDT, Heritage, Pfizer Inc., Baxter, AbbVie Inc., Glenmark, Siemens, Thermo Fisher Scientific, Bristol-Myers Squibb Company, B. Braun Melsungen AG, Smith & Nephew plc, GlaxoSmithKline plc., among other domestic and global players. The aneurysm treatment market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-